Moderator of

• 28315

  +

  11 - Surgically Resectable (ID 11)

  • Event: TTLC 2019
  • Type: General Session
  • Track:
  • Presentations: 10
  • Moderators:Nasser Altorki, Raymond Osarogiagbon
  • Coordinates: 2/22/2019, 08:00 - 09:05, Starlight Ballroom

  • 28435

    +

    Adjuvant Alchemist ALK TKIs (ID 11.06)

    08:00 - 09:05  |  Author(s): David Gerber
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 28434

    +

    Adjuvant IO (ID 11.05)

    08:00 - 09:05  |  Author(s): Penelope Bradbury
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 28438

    +

    LCMC4 Umbrella (ID 11.09)

    08:00 - 09:05  |  Author(s): Jamie Chaft
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 28431

    +

    Neoadjuvant Atezolizumab (LCMC3) and Pembrolizumab (ID 11.02)

    08:00 - 09:05  |  Author(s): Jay Lee
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 28432

    +

    Neoadjuvant Chemo + Atezolizumab (ID 11.03)

    08:00 - 09:05  |  Author(s): Catherine Shu
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 28437

    +

    Neoadjuvant Crizotinib ALK ROS and MET (ID 11.08)

    08:00 - 09:05  |  Author(s): Caroline McCoach
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 28433

    +

    Neoadjuvant Nivolumab +/- Ipilimumab (NEOSTAR) (ID 11.04)

    08:00 - 09:05  |  Author(s): Tina Cascone
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 28436

    +

    Osimertinib EGFR Mutant (ID 11.07)

    08:00 - 09:05  |  Author(s): Collin Blakely
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 28439

    +

    Science (ID 11.10)

    08:00 - 09:05  |  Author(s): David Harpole
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.

  • 28430

    +

    Surgery Considerations After IO or TKI (ID 11.01)

    08:00 - 09:05  |  Author(s): Erin Gillaspie
    • Abstract
    • Slides

    Abstract not provided

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.